Ionis Pharmaceuticals Inc (IONS)
31.15
-0.57
(-1.80%)
USD |
NASDAQ |
Mar 28, 16:00
31.16
+0.01
(+0.03%)
After-Hours: 20:00
Ionis Pharmaceuticals Max Drawdown (5Y): 70.27% for Feb. 28, 2025
View 4,000+ Financial Data Types:
Add
Browse
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Biogen Inc | 67.83% |
| Catalyst Pharmaceuticals Inc | 64.87% |
| Alnylam Pharmaceuticals Inc | 42.46% |
| Biomarin Pharmaceutical Inc | 53.26% |
| Ultragenyx Pharmaceutical Inc | 82.11% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -14.69 |
| Beta (5Y) | 0.2788 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 33.12% |
| Historical Sharpe Ratio (5Y) | -0.3231 |
| Historical Sortino (5Y) | -0.5811 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 15.36% |